+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Toxoplasmosis Drug"

toxoplasmosis Treatment Drugs Global Market Report 2024 - Product Thumbnail Image

toxoplasmosis Treatment Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Toxoplasmosis - Pipeline Review, H1 2020 - Product Thumbnail Image

Toxoplasmosis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 48 Pages
  • Global
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Toxoplasmosis is an infectious disease caused by the parasite Toxoplasma gondii. It is a major cause of morbidity and mortality in immunocompromised individuals, such as those with HIV/AIDS, and can cause severe birth defects in pregnant women. Treatment of toxoplasmosis is typically done with a combination of drugs, including sulfonamides, pyrimethamine, and clindamycin. The toxoplasmosis drug market is a subset of the larger infectious diseases drug market. It is composed of a variety of drugs used to treat and prevent toxoplasmosis, including sulfonamides, pyrimethamine, and clindamycin. These drugs are used in combination to treat the infection, and are often prescribed in combination with other drugs to prevent the development of drug resistance. Some companies in the toxoplasmosis drug market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Novartis. Show Less Read more